273 related articles for article (PubMed ID: 17373843)
21. Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysis.
Ménard C; Johann D; Lowenthal M; Muanza T; Sproull M; Ross S; Gulley J; Petricoin E; Coleman CN; Whiteley G; Liotta L; Camphausen K
Cancer Res; 2006 Feb; 66(3):1844-50. PubMed ID: 16452246
[TBL] [Abstract][Full Text] [Related]
22. An approach to the characterization of serum low-molecular weight proteins/peptides in liver injury using SELDI-TOF MS and factor analysis.
Liu X; Li L; Zhang G; Sheng G; Xu W
Clin Biochem; 2007 Nov; 40(16-17):1266-71. PubMed ID: 17706629
[TBL] [Abstract][Full Text] [Related]
23. Biomarker discovery in serum/plasma using surface enhanced laser desorption ionization time of flight (SELDI-TOF) mass spectrometry.
Ndao M
Methods Mol Biol; 2012; 818():67-79. PubMed ID: 22083816
[TBL] [Abstract][Full Text] [Related]
24. Proteomic patterns: their potential for disease diagnosis.
Xiao Z; Prieto D; Conrads TP; Veenstra TD; Issaq HJ
Mol Cell Endocrinol; 2005 Jan; 230(1-2):95-106. PubMed ID: 15664456
[TBL] [Abstract][Full Text] [Related]
25. Mass spectrometric profiling - a diagnostic tool in fish?
Provan F; Bjørnstad A; Pampanin DM; Lyng E; Fontanillas R; Andersen OK; Koppe W; Bamber S
Mar Environ Res; 2006 Jul; 62 Suppl():S105-8. PubMed ID: 16764920
[TBL] [Abstract][Full Text] [Related]
26. [Discovery of disease biomarkers by ProteinChip system; clinical proteomics as noninvasive diagnostic tool].
Tomosugi N
Rinsho Byori; 2004 Dec; 52(12):973-9. PubMed ID: 15675343
[TBL] [Abstract][Full Text] [Related]
27. [Establishment of endometriosis diagnostic model using plasma protein profiling].
Liu HY; Zheng YH; Zhang JZ; Leng JH; Sun DW; Liu ZF; Zhu L; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2009 Aug; 44(8):601-4. PubMed ID: 20003789
[TBL] [Abstract][Full Text] [Related]
28. Cardiovascular biomarker discovery by SELDI-TOF mass spectrometry.
Meilhac O; Delbosc S; Michel JB
Methods Mol Biol; 2007; 357():331-41. PubMed ID: 17172699
[TBL] [Abstract][Full Text] [Related]
29. [Serum proteomic patterns may assist the diagnosis of solitary pulmonary nodules].
Luo XY; Chen HQ; Sun YH; Zhou JH; Wang WF; Liao P; Xiang CQ
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):907-10. PubMed ID: 17533741
[TBL] [Abstract][Full Text] [Related]
30. Discovery and identification of potential biomarkers in a prospective study of chronic lymphoid malignancies using SELDI-TOF-MS.
Miguet L; Bogumil R; Decloquement P; Herbrecht R; Potier N; Mauvieux L; Van Dorsselaer A
J Proteome Res; 2006 Sep; 5(9):2258-69. PubMed ID: 16944938
[TBL] [Abstract][Full Text] [Related]
31. Toward the proteomic identification of biomarkers for the prediction of HBV related hepatocellular carcinoma.
He QY; Zhu R; Lei T; Ng MY; Luk JM; Sham P; Lau GK; Chiu JF
J Cell Biochem; 2008 Feb; 103(3):740-52. PubMed ID: 17557278
[TBL] [Abstract][Full Text] [Related]
32. A novel approach using MALDI-TOF/TOF mass spectrometry and prestructured sample supports (AnchorChip Technology) for proteomic profiling and protein identification.
Leung SM; Pitts RL
Methods Mol Biol; 2008; 441():57-70. PubMed ID: 18370311
[TBL] [Abstract][Full Text] [Related]
33. Proteomics blood testing to distinguish chronic rhinosinusitis subtypes.
Das S; Maeso PA; Becker AM; Prosser JD; Adam BL; Kountakis SE
Laryngoscope; 2008 Dec; 118(12):2231-4. PubMed ID: 18978510
[TBL] [Abstract][Full Text] [Related]
34. Optimized conditions for a quantitative SELDI TOF MS protein assay.
Lomas L; Clarke CH; Thulasiraman V; Fung E
Methods Mol Biol; 2012; 818():1-10. PubMed ID: 22083812
[TBL] [Abstract][Full Text] [Related]
35. Clinical proteomics in breast cancer: a review.
Gast MC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
[TBL] [Abstract][Full Text] [Related]
36. ProteoMiner™ and SELDI-TOF-MS: a robust and highly reproducible combination for biomarker discovery from whole blood serum.
Fröbel J; Hartwig S; Passlack W; Eckel J; Haas R; Czibere A; Lehr S
Arch Physiol Biochem; 2010; 116(4-5):174-80. PubMed ID: 20662595
[TBL] [Abstract][Full Text] [Related]
37. Screening newborns for candidate biomarkers of type 1 diabetes.
McGuire JN; Eising S; Wägner AM; Pociot F
Arch Physiol Biochem; 2010; 116(4-5):227-32. PubMed ID: 20868220
[TBL] [Abstract][Full Text] [Related]
38. Improving feature detection and analysis of surface-enhanced laser desorption/ionization-time of flight mass spectra.
Carlson SM; Najmi A; Whitin JC; Cohen HJ
Proteomics; 2005 Jul; 5(11):2778-88. PubMed ID: 15986333
[TBL] [Abstract][Full Text] [Related]
39. [Proteomics technology for screening biomarkers of oligospermic candidates].
Yang H; Zhang J; Zhang W; Long W; Zhang XB
Zhonghua Nan Ke Xue; 2006 Jan; 12(1):39-42. PubMed ID: 16483157
[TBL] [Abstract][Full Text] [Related]
40. The application of SELDI-TOF mass spectrometry to mammalian cell culture.
Woolley JF; Al-Rubeai M
Biotechnol Adv; 2009; 27(2):177-84. PubMed ID: 19049820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
